Metrics manifesting the strongest concurrent validity with providers identified from these records related to those who co-prescribed benzodiazepines (e.g., valium) and high levels of opioid analgesics (e.g., oxycodone), as well as those who wrote temporally overlapping prescriptions. The report concludes with a discussion of a variety of uses to which these metrics may be put, as well as problems and opportunities related to their use. (Publisher abstract modified)
Downloads
Similar Publications
- Simultaneous Imaging of Latent Fingermarks and Detection of Analytes of Forensic Relevance by Laser Ablation Direct Analysis in Real Time Imaging-Mass Spectrometry (LADI-MS)
- Decomposition of Juvenile-Sized Remains: a Macro- and Microscopic Perspective
- Body Fluid Identification Using a Targeted mRNA Massively Parallel Sequencing Approach - Results of a EUROFORGEN/EDNAP Collaborative Exercise